HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Oct. 25, 2017 (HealthDay News) -- Blood product transfusion pre-hospital or within minutes of injury is associated with improved survival among medically evacuated U.S. military combat casualties in Afghanistan, according to a study published online Oct. 24 in the Journal of the American Medical Association.
Stacy A. Shackelford, M.D., from Fort Sam Houston in San Antonio, Texas, and colleagues examined the correlation of pre-hospital transfusion and time to initial transfusion with injury survival in a retrospective cohort study involving U.S. military combat casualties in Afghanistan. Data were included for 502 patients.
The researchers found that 5 percent of 55 pre-hospital transfusion recipients and 19 percent of 447 nonrecipients died within 24 hours of medical evacuation (MEDEVAC) rescue (between-group difference, −14 percent). By day 30, 11 and 23 percent had died (between-group difference, −12 percent). The adjusted hazard ratio for mortality associated with pre-hospital transfusion was 0.26 and 0.39 over 24 hours and 30 days, respectively. There were correlations for time to initial transfusion, regardless of location, with reduced 24-hour mortality only up to 15 minutes after MEDEVAC rescue (median, 36 minutes after injury: adjusted hazard ratio, 0.17).
"Among medically evacuated U.S. military combat causalities in Afghanistan, blood product transfusion pre-hospital or within minutes of injury was associated with greater 24-hour and 30-day survival than delayed transfusion or no transfusion," the authors write. "The findings support pre-hospital transfusion in this setting."
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 29, 2022